26/02/2026
Horses with equine metabolic syndrome (EMS) have ID, but so can some horses with pituitary pars intermedia dysfunction (PPID) as well as with certain illnesses or drugs such as corticosteroids.1 For this reason scientists are investigating temporary use of SGLT2i around the time of corticosteroid joint (intra-articular, or IA) injections as ID can lead to hyperinsulemia-associated laminitis (HAL).
Here's what you should know about SGLT2-inhibitor use in horses.